Roivant Sciences saw the highest growth of 0.66% in patent filings in June and 0.24% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.24%. GlobalData’s DataBook provides a comprehensive analysis of Roivant Sciences’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Roivant Sciences has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 60% filings and 100% grants. The United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Roivant Sciences is filings its patents. Among the top granted patent authorities, Roivant Sciences has 100% of its grants in United States(US).
AbbVie could be the strongest competitor for Roivant Sciences
In terms of grant share, Roivant Sciences stands in tenth position among its competitors. AbbVie and Roivant Sciences secured the top positions according to recent patent publication data.
Patents related to nanomedicine and rare diseases lead Roivant Sciences's portfolio
Roivant Sciences has the highest number of patents in nanomedicine followed by, rare diseases. For nanomedicine, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Inflammation related patents lead Roivant Sciences portfolio followed by pregnancy, and metrorrhagia (abnormal uterine bleeding)
Roivant Sciences has highest number of patents in inflammation followed by pregnancy, metrorrhagia (abnormal uterine bleeding), menorrhagia, and dysmenorrhea. For inflammation, nearly 4% of patents were filed and 5% of patents were granted in Q2 2024.
For comprehensive analysis of Roivant Sciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
